Welcome to LookChem.com Sign In|Join Free

CAS

  • or

23987-21-5

Post Buying Request

23987-21-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

23987-21-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 23987-21-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,3,9,8 and 7 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 23987-21:
(7*2)+(6*3)+(5*9)+(4*8)+(3*7)+(2*2)+(1*1)=135
135 % 10 = 5
So 23987-21-5 is a valid CAS Registry Number.

23987-21-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-Chloro-2-(2-methoxyethoxy)aniline

1.2 Other means of identification

Product number -
Other names 2-<Chloracetyl-N-methylamino>-5-chlor-benzophenon

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:23987-21-5 SDS

23987-21-5Downstream Products

23987-21-5Relevant articles and documents

Compound containing benzo[b]thiophene structure, and derivative, preparation method and application

-

, (2017/04/28)

The invention discloses a micromolecular organic compound as shown in a structural formula (I) and containing a benzo[b]thiophene structure and a micromolecular organic compound as shown in a structural formula (II) and containing a 3-bromobenzo[b]thiophe

N-(MONOCYCLIC ARYL),N'-PYRAZOLYL-UREA, THIOUREA, GUANIDINE AND CYANOGUANIDINE COMPOUNDS AS TRKA KINASE INHIBITORS

-

Paragraph 00505; 00511, (2014/06/11)

Compounds of Formula (I) or stereoisomers, tautomers, or pharmaceutically acceptable salts, solvates or prodrugs thereof, wherein Ring A, Ring C and X are as defined herein, are inhibitors of TrkA kinase and are useful in the treatment of diseases which can be treated with a TrkA kinase inhibitor such as pain, cancer, inflammation/inflammatory diseases, neurodegenerative diseases, certain infectious diseases, Sjogren's syndrome, endometriosis, diabetic peripheral neuropathy, prostatitis or pelvic pain syndrome.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 23987-21-5